First Responder Stack Research Guide: Growth, Recovery & Metabolic
The First Responder Stack combines three research protocols into one bundle: pulsatile GH release, tissue repair, and triple-agonist metabolic signaling.
Component overview
CJC-1295 (No DAC) + Ipamorelin — GHRH analog + selective GHRP for pulsatile growth-hormone release research.
Wolverine Stack (BPC-157 + TB-500) — pentadecapeptide + thymosin β-4 fragment for tissue-repair signaling research.
GLP-3 RT — triple GLP-1/GIP/glucagon receptor agonist for metabolic and body-composition research.
Compliance reminder
Sold and distributed for laboratory research use only. Not approved by the FDA for human consumption, diagnosis, treatment, or cure of any disease. Researchers are responsible for compliance with all applicable institutional, state, and federal regulations.
Frequently asked questions
What is in the First Responder Stack?
The bundle contains three 10 mg vials: CJC-1295 (No DAC) + Ipamorelin combination, Wolverine Stack (BPC-157 + TB-500), and GLP-3 RT.
Why these three?
The stack covers three orthogonal research axes: GH-axis pulsatility (CJC+Ipa), tissue-repair signaling (Wolverine), and triple-agonist metabolic modeling (GLP-3 RT) — a common combination for first-responder-focused recovery research.